过去一年中添加的文章,按日期排序

Aggressive pituitary tumors and carcinomas: modern classification, advances and prospects in treatment

LI Astafyeva, PL Kalinin… - Zhurnal voprosy …, 2024 - pubmed.ncbi.nlm.nih.gov
4 天前 - tumors require therapy with somatostatin analogues and dopamine agonists in
maximum possible doses. Chemotherapy with temozolomidepatients. Treatment of aggressive …

[PDF][PDF] Temozolomide on Aggressive Pituitary Adenomas: About 4 Cases and Review of the Literature

E Kerboua, C Mazouzi, R Benyahia, L Atroune… - researchgate.net
28 天前 - … complexity of treating malignant pituitary adenomas. The pituitary tumors examined
here are … The medical treatment of pituitary carcinoma is the same as that of large recurrent …

Challenges in diagnosis and management of silent corticotroph adenomas: insights from three case studies and literature review

X Zhao, Z Li, C Wang - Endocrine Abstracts, 2024 - endocrine-abstracts.org
49 天前 - temozolomide (TMZ) may be a novel therapeutic option to treat invasive pituitary
tumors… TMZ as the primary therapy for invasive pituitary tumors that have not responded to …

Are giant prolactinomas different from macroprolactinomas? The single-centre observation

KCM Aleksandra, A Bogusławska… - Endocrine …, 2024 - endocrine-abstracts.org
49 天前 - … In one case of aggressive tumour Temozolomide was implemented with a disease
stabilization. Cabergoline resistance was observed in 5/33% of GP vs 1/3, 85% of MP, P=…

Overview of pituitary malignancies

H Heshmati - Endocrine Abstracts, 2024 - endocrine-abstracts.org
49 天前 - … benign pituitary tumors and pituitary carcinomas. The diagnosis of pituitary carcinomas
… carcinomas has significantly improved since the introduction of temozolomide, a drug …

Recent Progress in Treatments of Pituitary Neuroendocrine Tumors (Pituitary Tumors)

H Nishioka - No Shinkei geka. Neurological Surgery, 2024 - europepmc.org
54 天前 - In the World Health Organization 2022 classification, a nomenclature change from
pituitary adenoma to pituitary neuroendocrine tumor (PitNET) was introduced to indicate rare …

Prolactinoma-the most common pituitary tumor. A literature review

K Olczyk, K ZajĄc, P Szczęsny, A Kupczak… - Polish Journal of …, 2024 - pjas.ansl.edu.pl
138 天前 - … resistant to standard therapeutic approaches or highly invasive pituitary tumors. An
example of this is the use of temozolomide in treatment. Research is also underway on other …

Genetic and Molecular Insights into Aggressive Prolactinomas: A Literature Review

YM Zohdy, A Rodas, J Maldonado… - … Surgery Part B: Skull …, 2024 - thieme-connect.com
140 天前 - Temozolomide has displayed promise as a pharmacological agent for treating APRL
patients, particularly in tumors with … pituitary tumors remains a subject of ongoing debate. …

Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide.

AL Carretti, F Ducray, E Jouanneau… - Minerva …, 2024 - europepmc.org
156 天前 - … Aggressive pituitary tumors are a subset of pituitary neoplasms, characterized by
unusually fast growth rate, invasiveness and overall resistance to optimized standard treatment…

Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomide

DDE Alcubierre, AL Carretti, F Ducray… - Minerva … - pubmed.ncbi.nlm.nih.gov
156 天前 - … Aggressive pituitary tumors are a subset of pituitary neoplasms, characterized by
unusually fast growth rate, invasiveness and overall resistance to optimized standard treatment…